Gene expression analyses showed that Cud C exhibited a gene profile that was similar to PI3K-AKT inhibitors (Wortmannin and LY-294002) suggesting that Cud C may induce its anti-tumor effects through the regulation of PI3K-AKT independent of NFκB signaling. This evidence concerns the gene AKT1 and neoplasm.